News
A Democrat introduced legislation in Congress to codify President Donald Trump’s executive order to reduce drug prices. Rep.
1hOpinion
ThyBlackMan on MSNDonald Trump’s Economic Agenda Exposes GOP’s Abandonment of Free Market Principles.None of this should surprise anyone paying attention. This administration is packed with advisers and surrogates who glorify ...
Amid rising prescription drug prices, local pharmacists are questioning federal efforts—like Donald Trump's executive order to lower costs—warning it could have unintended consequences.
A Trump administration plan to slash prescription drug prices by tying them to international markets will likely have minimal ...
Opinion
8hOpinion
The Daily Caller on MSNDems Who Clapped Like Seals For Biden’s Big Pharma Actions Do 180 On Trump Drug Pricing OrderCongressional Democrats who praised former President Joe Biden’s executive actions against America’s pharmaceutical industry are holding their praise for President Trump’s latest executive order.
Here’s what to know about the order and its potential impact on drug prices in the U.S. Could the Executive Order actually ...
This is misleading. Prices for most prescription drugs — unbranded generics are the exception — are higher in the U.S. than ...
According to the timeline laid out in President Donald Trump’s May 12 executive order, prescription drug price reductions would not happen "almost immediately." The order specifies a 30-day period to ...
12hOpinion
The Daily Caller on MSNMark Halperin Tells Charlie Kirk What He Thinks Is ‘Arguably’ Media’s ‘Biggest Mistake’ In Covering TrumpPolitical analyst Mark Halperin told Turning Point USA founder Charlie Kirk Wednesday that he believes the media makes a ...
President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche ...
U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...
President Donald Trump's executive order on drug pricing could potentially jeopardize Roche's extensive $50 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results